Mark Alberts is a Neurology physician affiliated with Hartford Hospital. OpenAlex indexes 389 publications with 31,745 citations (h-index 75); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Neurology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5323 Harry Hines Blvd
Dallas, TX 753907208
Telephone
214-645-0624Registry record last updated 26 Mar 2013.
Clinical trials
- Aspirin Resistance and Stroke Risk: Platelet Function Analysis in Patients With Ischemic Events
Sponsor: Northwestern University
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20252 payments
- Lilly USA, LLCProgram year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
86.5%Cholinesterase Inhibitor38.7%Donepezil Hcl100%Part D<11 patientsN-methyl-D-aspartate Receptor Antagonist28.8%Memantine Hcl Er100%Part D<11 patients+ 1 more class in this area
Blood & clotting
13.5%Factor Xa inhibitor13.5%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Incidence and Predictors of Major Adverse Cardiovascular Events in Patients With Established Atherosclerotic Disease or Multiple Risk Factors
Journal of the American Heart Association
2020 - Assessing stroke severity using electronic health record data: a machine learning approach
BMC Medical Informatics and Decision Making
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Karen Blank, MD
Hartford Hospital
Raymond McKay, MD
Hartford Hospital
Andrew Salner, MD
Hartford Hospital
Jeffrey Kluger, MD
Hartford Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”